Evidence map›Paper›PMID 34119036›Full record

ArticleThe lancet. Gastroenterology & hepatology2021

Stent insertion for incurable oesophageal carcinoma: what is the optimal treatment? - Authors' reply.

Anthony Byrne, Douglas Adamson, Catharine Porter, Christopher Hurt

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The lancet. Gastroenterology & hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anthony ByrneMarie Curie Research Centre, Cardiff University, Cardiff, UK; Velindre University NHS Trust, Cardiff, UK. Electronic address: anthony.byrne2@wales.nhs.uk.
Douglas AdamsonTayside Cancer Centre, Ninewells Hospital, Dundee, UK.
Catharine PorterCentre for Trials Research, Cardiff University, Cardiff UK.
Christopher HurtCentre for Trials Research, Cardiff University, Cardiff UK.
Ninewells Hospital · GB

Funding

Cancer Research UK 25350
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinomaEsophageal NeoplasmsHumansStents

Identifiers

PMID34119036
OpenAlexW3172353258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.